A novel mutation of COL2A1 resulting in dominantly inherited rhegmatogenous retinal detachment

被引:33
作者
Richards, AJ
Meredith, S
Poulson, A
Bearcroft, P
Crossland, G
Baguley, DM
Scott, JD
Snead, MP
机构
[1] Addenbrookes NHS Trust, Vitreoretinal Serv, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[3] Addenbrookes NHS Trust, Dept Radiol, Cambridge CB2 2QQ, England
[4] Addenbrookes NHS Trust, Dept Audiol, Cambridge CB2 2QQ, England
关键词
D O I
10.1167/iovs.04-1017
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To determine the molecular defect in a family with autosomal dominant rhegmatogenous retinal detachment ( DRRD), and to investigate missplicing as a possible phenotypic modifier of mutations in COL2A1. METHODS. Clinical examination of the family and linkage analysis using markers flanking COL2A1 and COL11A1, the known loci for Stickler syndrome; mutation screening of COL2A1; construction of splicing reporter minigenes and transfection into cultured cells; and RT- PCR analysis of reporter specific transcripts. RESULTS. A family with DRRD showed no systemic clinical signs ( skeletal, orofacial, or auditory) usually associated with Stickler syndrome. Linkage analysis excluded COL11A1 as the disease locus but could not exclude COL2A1. Mutation screening of COL2A1 identified a novel G118R mutation in type II collagen. Transfection of minigenes carrying mutations associated with DRRD ( G118R, R453X, and L467F) into cultured cells detected no missplicing of mRNA from mutant constructs. CONCLUSIONS. Mutations outside the alternatively spliced exon 2 region of COL2A1 can also result in an ocular only phenotype. There was no evidence that missplicing modifies the phenotype of these mutations, suggesting that the minimal or absent systemic features demonstrated by the G118R and L467F mutations are the result of the biophysical changes imparted on the collagen molecule.
引用
收藏
页码:663 / 668
页数:6
相关论文
共 37 条
[1]   Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene [J].
Aznarez, I ;
Chan, EM ;
Zielenski, J ;
Blencowe, BJ ;
Tsui, LC .
HUMAN MOLECULAR GENETICS, 2003, 12 (16) :2031-2040
[2]  
BOEHRINGER H R, 1960, Ophthalmologica, V139, P330
[3]   SCNM1, a putative RNA splicing factor that modifies disease severity in mice [J].
Buchner, DA ;
Trudeau, M ;
Meisler, MH .
SCIENCE, 2003, 301 (5635) :967-969
[4]   INHERITED DISORDERS OF COLLAGEN GENE STRUCTURE AND EXPRESSION [J].
BYERS, PH .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1989, 34 (01) :72-80
[5]   A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancer [J].
Caputi, M ;
Kendzior, RJ ;
Beemon, KL .
GENES & DEVELOPMENT, 2002, 16 (14) :1754-1759
[6]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[7]   A REGULATORY MECHANISM THAT DETECTS PREMATURE NONSENSE CODONS IN T-CELL RECEPTOR TRANSCRIPTS IN-VIVO IS REVERSED BY PROTEIN-SYNTHESIS INHIBITORS IN-VITRO [J].
CARTER, MS ;
DOSKOW, J ;
MORRIS, P ;
LI, SL ;
NHIM, RP ;
SANDSTEDT, S ;
WILKINSON, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) :28995-29003
[8]   The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C→T mutation [J].
Chiba-Falek, O ;
Kerem, E ;
Shoshani, T ;
Aviram, M ;
Augarten, A ;
Bentur, L ;
Tal, A ;
Tullis, E ;
Rahat, A ;
Kerem, B .
GENOMICS, 1998, 53 (03) :276-283
[9]   Nomenclature for the description of human sequence variations [J].
den Dunnen, JT ;
Antonarakis, E .
HUMAN GENETICS, 2001, 109 (01) :121-124
[10]   Clinical variability of Stickler syndrome: Role of exon 2 of the collagen COL2A1 gene [J].
Donoso, LA ;
Edwards, AO ;
Frost, AT ;
Ritter, R ;
Ahmad, N ;
Vrabec, T ;
Rogers, J ;
Meyer, D ;
Parma, S .
SURVEY OF OPHTHALMOLOGY, 2003, 48 (02) :191-203